B
Boqii Holding Ltd
AMEX:BQ
Boqii Holding Ltd
AMEX:BQ
Price:
0.803
USD
2.98%
Market Cap:
$3.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Boqii Holding Ltd
AMEX:BQ
|
CN |
|
COSCO SHIPPING Development Co Ltd
SSE:601866
|
CN |
|
J
|
Jayshree Chemicals Ltd
BSE:506520
|
IN |
|
C
|
Cue Health Inc
OTC:HLTHQ
|
US |
|
Shanghai Shyndec Pharmaceutical Co Ltd
SSE:600420
|
CN |
|
Xbrane Biopharma AB
STO:XBRANE
|
SE |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
US |
Income Statement
Earnings Waterfall
Boqii Holding Ltd
Boqii Holding Ltd
Income Statement
Boqii Holding Ltd
Boqii Holding Ltd
Currency: CNY
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
28
|
0
|
0
|
0
|
21
|
0
|
3
|
13
|
9
|
3
|
7
|
3
|
|
| Revenue |
395
N/A
|
624
+58%
|
937
+50%
|
1 011
+8%
|
1 094
+8%
|
1 147
+5%
|
1 167
+2%
|
1 186
+2%
|
1 180
-1%
|
1 172
-1%
|
1 092
-7%
|
892
-18%
|
250
-72%
|
469
+88%
|
427
-9%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(321)
|
(508)
|
(764)
|
(824)
|
(894)
|
(934)
|
(933)
|
(944)
|
(923)
|
(918)
|
(859)
|
(704)
|
(198)
|
(368)
|
(324)
|
|
| Gross Profit |
74
N/A
|
117
+57%
|
173
+48%
|
187
+8%
|
200
+7%
|
213
+7%
|
234
+10%
|
243
+4%
|
257
+6%
|
255
-1%
|
234
-8%
|
187
-20%
|
52
-72%
|
101
+95%
|
103
+2%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(144)
|
(208)
|
(358)
|
(393)
|
(406)
|
(426)
|
(384)
|
(381)
|
(364)
|
(340)
|
(297)
|
(293)
|
(79)
|
(160)
|
(152)
|
|
| Selling, General & Administrative |
(144)
|
(221)
|
(372)
|
(394)
|
(407)
|
(427)
|
(384)
|
(381)
|
(364)
|
(340)
|
(297)
|
(255)
|
(79)
|
(161)
|
(153)
|
|
| Other Operating Expenses |
0
|
13
|
14
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
(38)
|
1
|
1
|
1
|
|
| Operating Income |
(70)
N/A
|
(91)
-30%
|
(185)
-103%
|
(206)
-11%
|
(205)
+0%
|
(212)
-3%
|
(150)
+29%
|
(138)
+8%
|
(106)
+23%
|
(85)
+20%
|
(63)
+26%
|
(106)
-68%
|
(27)
+74%
|
(59)
-119%
|
(49)
+17%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(14)
|
(8)
|
(9)
|
(2)
|
4
|
(4)
|
(3)
|
2
|
(6)
|
(9)
|
(6)
|
(5)
|
(2)
|
0
|
3
|
|
| Non-Reccuring Items |
13
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
(37)
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
1
|
14
|
7
|
12
|
8
|
(1)
|
1
|
4
|
13
|
(1)
|
(4)
|
(0)
|
(0)
|
11
|
|
| Pre-Tax Income |
(71)
N/A
|
(98)
-38%
|
(181)
-84%
|
(193)
-7%
|
(190)
+2%
|
(208)
-9%
|
(154)
+26%
|
(135)
+12%
|
(108)
+20%
|
(81)
+25%
|
(107)
-32%
|
(115)
-8%
|
(30)
+74%
|
(59)
-98%
|
(36)
+39%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
1
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
1
|
(1)
|
|
| Income from Continuing Operations |
(70)
|
(98)
|
(180)
|
(193)
|
(188)
|
(206)
|
(152)
|
(133)
|
(108)
|
(80)
|
(106)
|
(114)
|
(29)
|
(59)
|
(37)
|
|
| Income to Minority Interest |
0
|
(0)
|
(2)
|
(1)
|
1
|
3
|
5
|
4
|
1
|
0
|
3
|
3
|
2
|
4
|
(2)
|
|
| Equity Earnings Affiliates |
(0)
|
(0)
|
(0)
|
(1)
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Net Income (Common) |
(167)
N/A
|
(235)
-41%
|
(122)
+48%
|
(86)
+29%
|
(31)
+64%
|
(6)
+79%
|
(147)
-2 181%
|
(129)
+12%
|
(106)
+17%
|
(80)
+25%
|
(104)
-29%
|
(111)
-8%
|
(28)
+75%
|
(55)
-98%
|
(39)
+30%
|
|
| EPS (Diluted) |
-2.46
N/A
|
-3.46
-41%
|
-1.74
+50%
|
-241.67
-13 789%
|
-2.74
+99%
|
-0.57
+79%
|
-13.01
-2 182%
|
-355.66
-2 634%
|
-9.28
+97%
|
-36.31
-291%
|
-46.97
-29%
|
-48.11
-2%
|
-2.58
+95%
|
-0.27
+90%
|
-12.06
-4 367%
|
|
Switch to:
Switch to:
See Also
Discover More
